Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Clinical Trials in Taiwan / NCT07447999
Recruiting Observational

Multimodal Deep Learning Model for Predicting the Apnea-Hypopnea Index in Obstructive Sleep

NCT07447999 · tracked via the Priya Life Science Taiwan tracker
Sponsor
Fu Jen Catholic University
Phase
Observational
Started
2025-09-05
Last updated
2026-03-05

Condition(s) studied

Obstructive Sleep Apnea (OSA)Polysomnography

Investigational drug(s) / intervention(s)

electronic stethoscopefingertip pulse oximeterpressure-sensing mattresses

electronic stethoscope: digital device amplifying and recording cardiopulmonary sounds

fingertip pulse oximeter: a small device placed on the finger to measure blood oxygen saturation (SpO₂) and pulse rate noninvasively.

pressure-sensing mattresses: using ballistocardiography (BCG) for monitoring respiration and heart rate

Study summary

This study aims to develop a multimodal deep learning model that integrates noninvasive signals to predict the severity of obstructive sleep apnea. By establishing a clinically viable and user-friendly monitoring tool, the study seeks to enhance early screening accessibility and support the development of home-based sleep care systems.

Eligibility

Sex
ALL
Min age
30 Years
Max age
75 Years
Healthy volunteers
No
Inclusion Criteria: * age 30-75 years * clinically suspected obstructive sleep apnea and scheduled for polysomnography * willing and able to provide written informed consent Exclusion Criteria: * intolerance to the electronic stethoscope or fingertip pulse oximeter * significant structural airway abnormalities * arrhythmia * neuromuscular disorders * pregnancy * hospitalization within the past 1 month * inability to provide informed consent or requiring legal guardian consent

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Fu Jen Catholic University Hospital, Fu Jen Catholic University New Taipei City Taiwan Recruiting

More Fu Jen Catholic University trials in Taiwan

Comparing Ultrasonic and Conventional Spirometry in Chronic Respiratory Disease Recruiting
Expression of SLC25A48 in Chronic Obstructive Pulmonary Disease Recruiting
AI-Powered Virtual Human Simulation in Students Starting soon
Use of 3D Printing High-fidelity Craniofacial Manikin to Teach Noninvasive Positive Pressure Ventilation Recruiting
Effects of Mobilization Using a Powered Lower-limb Exoskeleton With Prolonged Mechanical Ventilation Recruiting

Other trials for the same condition

Development of a Multimodal Deep Learning Model for Pediatric Patients Starting soon
Intermittent-Hypoxia Inhibits Neutrophil Extracellular Traps Formation: Role of Cathelicidins Starting soon
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07447999 on ClinicalTrials.gov ↗ ← All trials in Taiwan